EUVIMEDEUVIMED entdecken
Open Access

Relationships among symptoms of gastroparesis to those of avoidant/restrictive food intake disorder in patients with gastroparesis

Erin Hollis, Helen Burton Murray, Henry P Parkman iD

Neurogastroenterology & Motility · 2024-02 · 36 (2)

DOI: 10.1111/nmo.14725 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurogastroenterology & Motility, online erschienen am 07.12.2023. Verfasst von Erin Hollis und 2 weiteren Autor:innen. Beteiligte Einrichtung: Lankenau Medical Center, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Avoidant Restrictive Food Intake Disorder, Feeding and Eating Disorders, Gastroparesis. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients with symptoms of gastroparesis (Gp) often reduce food intake in attempt to manage their symptoms. Up to 40% of adults with Gp have been reported to have symptoms of a non‐body image‐based eating disorder, avoidant/restrictive food intake disorder (ARFID). However, whether ARFID symptoms precede or follow the diagnosis of Gp is unknown.

Methods

From January 2021 to January 2022, consecutive adult patients with Gp at an academic center completed self‐report surveys for Gp symptom severity (patient assessment of upper gastrointestinal symptoms; PAGI‐SYM) and for ARFID (nine‐item ARFID screen; NIAS). Key Results One hundred and seven patients (age 45.4 ± 17.2 yrs, 84.1% female, BMI 26.4 ± 7.3) with Gp (4‐h gastric retention 33.5 ± 21.8%) were included. Eighty‐two of the 107 Gp patients (77%) screened positive for ARFID. Positive ARFID screen was most often on the NIAS appetite subscale (84%) and fear subscale (76%), with a lower positive screen rate on the picky subscale (45%). Of the Gp who screened positive for ARFID, 38% reported that eating difficulties came after their Gp diagnosis, whereas 17% reported that eating difficulties preceded their Gp diagnosis, and 15% reported that both began at the same time.

Conclusions

Many (77%) patients with Gp screened positive for ARFID. In Gp patients with ARFID, the Gp diagnosis was more likely to precede the development of eating difficulties. Thus, a subset of patients with Gp may be at risk for developing ARFID. Further longitudinal research is needed to confirm findings and identify risk factors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Avoidant Restrictive Food Intake DisorderFeeding and Eating DisordersGastroparesisAdultHumansFemaleMiddle AgedMaleRetrospective StudiesEating

Stichwörter der Autor:innen

avoidant/restrictive food intake disordereating disordergastric retentiongastroparesisrestrictive eating

Autor:innen und Institutionen

  • Lankenau Medical Center, Philadelphia, Pennsylvania, USA.
  • Department of Psychiatry, Eating Disorders Clinical Research Program, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Gastroenterology Division, Temple University Hospital, Philadelphia, Pennsylvania, USA.

ORCID-Profile: Henry P Parkman

Förderung

  • NIDDK NIH HHS

Zitieren

APA

Hollis, E., Murray, H. B., & Parkman, H. P. (2024). Relationships among symptoms of gastroparesis to those of avoidant/restrictive food intake disorder in patients with gastroparesis. Neurogastroenterology & Motility, 36(2). https://doi.org/10.1111/nmo.14725

Vancouver

Hollis E, Murray HB, Parkman HP. Relationships among symptoms of gastroparesis to those of avoidant/restrictive food intake disorder in patients with gastroparesis. Neurogastroenterology & Motility. 2024;36(2). doi:10.1111/nmo.14725

BibTeX
@article{Hollis2024,
  author = {Hollis, Erin and Murray, Helen Burton and Parkman, Henry P},
  title = {Relationships among symptoms of gastroparesis to those of avoidant/restrictive food intake disorder in patients with gastroparesis},
  journal = {Neurogastroenterology & Motility},
  year = {2024},
  volume = {36},
  number = {2},
  doi = {10.1111/nmo.14725}
}
Kostenlos starten →